Vertex Pharmaceuticals, Inc. (VRTX)
476.90
+7.63
(+1.63%)
USD |
NASDAQ |
Feb 20, 16:00
472.57
-4.33
(-0.91%)
After-Hours: 06:56
Vertex Pharmaceuticals Research and Development Expense (Quarterly) : 973.70M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Moderna, Inc. | 708.00M |
| Gilead Sciences, Inc. | 1.565B |
| Eli Lilly & Co. | 3.802B |
| Merck & Co., Inc. | 3.992B |
| Pfizer Inc. | 3.206B |